As of Feb 17
| -0.68 / -1.27%|
The 15 analysts offering 12-month price forecasts for Metlife have a median target of 61.00, with a high estimate of 67.00 and a low estimate of 50.00. The median estimate represents a +15.16% increase from the last price of 52.97.
The current consensus among 20 polled investment analysts is to Buy stock in Metlife. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.